Return Policy
Drug Regulatory Constraints & Quality Assurance Returns
As regulated pharmaceutical formulations, goods once sold are not returnable except in verified cases of transit damage or manufacturing defect reported within 48 hours.
1. Regulatory Constraints on Pharmaceutical Goods
Under the Drugs and Cosmetics Act 1940 and Good Distribution Practices (GDP), medicinal formulations once dispatched from our cGMP warehouse cannot be returned for retail exchange or credit once secondary packaging seals are broken.
2. Eligible Grounds for Return
Manufacturing Defect: Verified batch discoloration, seal leakage, or packaging irregularity reported prior to distributor onward distribution.
Transit Damage: Physical breakage occurring during transport, provided the damage is recorded on the carrier Delivery Challan / LR copy upon arrival and reported within 48 hours with photographic/video proof.
Statutory Recall: Official voluntary or regulatory batch recall notices issued by the Drug Controller.
3. Ineligible Scenarios
Goods nearing expiry due to sluggish distributor sales or distributor over-forecasting.
Products damaged due to improper storage, dampness, direct sunlight, or pest infestation at distributor premises.
Broken outer shipper cartons where individual blister strips / bottle units remain undamaged.
4. Return Authorization (RMA) Protocol
Distributors must contact our Quality Assurance Desk at [email protected] or +91 98253 24786 within 48 hours of shipment receipt to obtain an official Return Material Authorization (RMA) number.
Shipments returned without prior written RMA authorization will not be accepted at our receiving dock.
For regulatory verifications, legal clarifications, or commercial grievances regarding this policy document: